The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjects
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The effect of LCZ696 (sacubitril/valsartan) on amyloid-β concentrations in cerebrospinal fluid in healthy subjects
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 81, Issue 5, Pages 878-890
Publisher
Wiley
Online
2015-12-12
DOI
10.1111/bcp.12861
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Amyloid-Beta Protein Clearance and Degradation (ABCD) Pathways and their Role in Alzheimer’s Disease
- (2015) Robert Baranello et al. Current Alzheimer Research
- The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
- (2014) José Luis Molinuevo et al. Alzheimers & Dementia
- The dark sides of amyloid in Alzheimer's disease pathogenesis
- (2014) Pierpaolo Sorrentino et al. FEBS LETTERS
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Longitudinal Change in CSF Biomarkers in Autosomal-Dominant Alzheimer's Disease
- (2014) A. M. Fagan et al. Science Translational Medicine
- Combined Neprilysin and Renin-Angiotensin System Inhibition for the Treatment of Heart Failure
- (2014) Orly Vardeny et al. JACC-Heart Failure
- Fluid biomarkers in Alzheimer’s disease – current concepts
- (2013) Christoffer Rosén et al. Molecular Neurodegeneration
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
- (2013) Jean-Charles Lambert et al. NATURE GENETICS
- Increased in Vivo Amyloid- 42 Production, Exchange, and Loss in Presenilin Mutation Carriers
- (2013) R. Potter et al. Science Translational Medicine
- Proteolytic Degradation of Amyloid -Protein
- (2013) T. Saido et al. Cold Spring Harbor Perspectives in Medicine
- Trafficking and Proteolytic Processing of APP
- (2013) C. Haass et al. Cold Spring Harbor Perspectives in Medicine
- APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38
- (2012) Maria Luisa Moro et al. ACTA NEUROPATHOLOGICA
- Cerebrospinal Fluid Levels ofβ-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
- (2012) Peder Buchhave ARCHIVES OF GENERAL PSYCHIATRY
- Molecular Plasticity Regulates Oligomerization and Cytotoxicity of the Multipeptide-length Amyloid-β Peptide Pool
- (2012) Annelies Vandersteen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes
- (2012) Iryna Benilova et al. NATURE NEUROSCIENCE
- Amyloid-β forms fibrils by nucleated conformational conversion of oligomers
- (2011) Jiyong Lee et al. Nature Chemical Biology
- CSF amyloid 38 as a novel diagnostic marker for dementia with Lewy bodies
- (2010) E. Mulugeta et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- -Secretase-dependent amyloid- is increased in Niemann-Pick type C: A cross-sectional study
- (2010) N. Mattsson et al. NEUROLOGY
- Aggregation and catabolism of disease-associated intra-Aβ mutations: reduced proteolysis of AβA21G by neprilysin
- (2008) Vicki Betts et al. NEUROBIOLOGY OF DISEASE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now